Compare ADAG & GPMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADAG | GPMT |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | China | United States |
| Employees | 138 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.3M | 119.9M |
| IPO Year | 2020 | N/A |
| Metric | ADAG | GPMT |
|---|---|---|
| Price | $2.96 | $1.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $8.00 | $3.00 |
| AVG Volume (30 Days) | 108.8K | ★ 234.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.36% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3,688.61 | $543.95 |
| Revenue Next Year | $17.39 | $33.91 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.33 | $1.61 |
| 52 Week High | $3.53 | $3.12 |
| Indicator | ADAG | GPMT |
|---|---|---|
| Relative Strength Index (RSI) | 54.77 | 35.34 |
| Support Level | $1.64 | $1.64 |
| Resistance Level | $3.19 | $2.71 |
| Average True Range (ATR) | 0.30 | 0.10 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 48.01 | 16.91 |
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.